1 in 3
of the world’s population
lives with Fatty Liver Disease (FLD).*
Untreated FLD leads to inflammation, cirrhosis, type 2 diabetes, hypertension, cardiovascular illness and ultimately liver cancer. FibroScan® screening is the simple and effective method to diagnose and fight FLD before it takes hold.
FLD is likely to become the leading cause of end-stage liver disease in the coming decades. But we can do something about it today.
*(Journal of Hepatology, 2023)
Hear from our founder
Louise Campbell is a globally recognised leader in liver health and a Fellow of The Royal College of Physicians. Louise’s experience includes leading teams that have used FibroScan® across 4 continents, assisting governments in public health initiatives and discussing Fatty Liver Disease on major news platforms.
Interested in a consult?
Click here to book a consultation and FibroScan® with Louise Campbell at our Tawazun Health HQ, in Harley Street London.
FibroScan® is a non-invasive, quick and painless test recognised as the new standard for Fatty Liver Disease (FLD) diagnosis
With over 4,800 medical publications worldwide, and recommendations in 180 clinical guidelines, major institutions worldwide including the Global Liver Institute, British Liver Trust and Australian Liver Foundation support FibroScan®.
FibroScan® uses sound waves to measure liver fattiness and stiffness
FibroScan® is a painless, non-invasive method for identifying the early signs of FLD. Unlike blood tests and biopsies, there is no discomfort, no sample handling, and no need to wait for results.
Actionable results, fast
Each FibroScan® takes just 15 minutes and results are ready immediately. Presenting liver health scores in a simple ‘traffic light’ system has proven exceedingly effective in sparking positive lifestyle changes.
Learn more about the process of having a FibroScan® with Echosens’ training tutorial.
Corporate
FibroScan® helps you make a healthy workforce your competitive advantage, reducing the costs of low productivity and absenteeism caused by FLD.
Health Screening
Tawazun Health is dedicated to improving standards for FLD screening and management through research, education and innovation.
Public Health
Working with health authorities globally to improve patient outcomes by introducing FibroScan® into primary care at the earliest opportunities to prevent the onset of avoidable diseases.
Individual
We are committed to making FibroScan® accessible and affordable, with instant results and simple actionable lifestyle recommendations for you.
Latest from Tawazun
Why You Might Need A Fibroscan: Exploring Its Importance In Liver Health
Why you should have a Fibroscan® Screening In the corporate world, where occupational health is becoming more and more important, understanding the significance of liver health cannot be overstated. For corporate entities, particularly those operating in industries...
The Somerset NHS FT’s Revolutionary Identification System for Liver Disease
In an era marked by astonishing technological advancements, the healthcare sector stands at the forefront of innovation, continually striving to improve patient care and outcomes. A testament to this progress is the groundbreaking achievement of the Somerset NHS...
Exploring Louise Campbell’s Expertise and Tawazun Health’s Impact on FibroScan
In the dynamic realm of medical science, breakthroughs are driven by the convergence of expertise and innovative partnerships. A shining example of this synergy is found in the remarkable story of Louise Campbell, a leading expert in the field of FibroScan technology,...